Last Updated: Nov. 18th, 2020
Deep01(“us”, “we”, or “our”) operates http://www.deep01.com/ (the “Site”). This page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Site.
We use your Personal Information only for providing and improving the Site. By using the Site, you agree to the collection and use of information in accordance with this policy.
While using Our Service, We may ask You to provide Us with certain personally identifiable information that can be used to contact or identify You. The information might be collected in the following ways but not limited to it.
We are the sole owners of the information collected on the Site. We will not sell or rent this information to anyone. We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization, other than as necessary to fulfill your request. We may use Personal Data for the following purposes:
The security of Your Personal Data is important to Us. However, no method of transmission over the Internet, or method of electronic storage is 100% secure. While We strive to use commercially acceptable means to protect Your Personal Data, We cannot guarantee its absolute security.
First Deep Learning FDA Clearance in Asia-Pacific
Deep01 is a Taiwan-based AI software company that located in Taipei. Our focus is developing advanced AI-based SaMD (Software as a Medical Device) for decision support that aims to assist physicians to expedite patient treatment. Deep01 is the first AI company in the world to obtain both U.S. and Taiwan FDA clearances.
Our technology analyzes brain CT imaging to provide smart solutions for notifying and helping ER physicians, radiologists to prioritize the time-sensitive and life-threatening cases and better manage patients in the golden hour.
Deep01 is empowering physicians with our innovative AI solutions.
The team members of Deep01 are from Harvard University, Cambridge University, Carnegie Mellon University, National Taiwan University, National Tsing Hua University, and National Chiao Tung University with profound international work experience and from senior physicians in the U.S. and Taiwan.
David Chou, the founder and CEO of Deep01, graduated from Carnegie Mellon University Computer Science and National Taiwan University Electrical Engineering, and was a research fellow at Harvard University. David was also awarded 2020 Ten Outstanding Young Persons (十大傑出青年) by President.
Closed US$2.7 million fundraising in Pre-A round led by ASUS
- followed by ITRI (Industrial Technology Research Institute), III (Institute for Information Industry), and BE Capital
2020 Taiwan Top 10 Startups and Ranked 1st
- by the Minister of Science and Technology.
The first deep learning Taiwan FDA clearance in the world
Taiwan Innovation Award
1st place in AWS Cloud Challenge
- with a grand prize of $1.8M NTD cash
The first deep learning U.S. FDA clearance in Asia-Pacific
Top-picked as Harvard research fellow
- with full scholarship by Leap Program of Taiwan government
Won 2nd place in Dark Horse Contest
- which is the biggest startup contest in China
Won the 2nd place in Beijing Taiwan Startup Contest
- out of 900+ teams
U.S. Plug & Play invested